Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|February 3, 2004
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapyDavid-Alexandre Gross, Stéphanie Graff-Dubois, Paule Opolon, et al.
Cancer Research|March 26, 2002
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activityDanila Valmori, Carmen Scheibenbogen, Valerie Dutoit, et al.
Cancer Immunity|May 20, 2004
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFADanielle Liénard, Donata Rimoldi, Marie Marchand, et al.
Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical TrialAmandine Legat, Hélène Maby-El Hajjami, Petra Baumgaertner, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Blood|November 6, 2007
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responsesMichael Schmitt, Anita Schmitt, Markus T Rojewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigenPierre-Yves Dietrich, Frédérique-Anne Le Gal, Valérie Dutoit, et al.
Plos One|September 13, 2012
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigenRona Y Zhao, Nicole A Mifsud, Kun Xiao, et al.
Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.
Pageof 13